Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms
- PMID: 9624503
- PMCID: PMC105631
- DOI: 10.1128/AAC.42.6.1503
Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms
Abstract
Trovafloxacin pneumococcal and staphylococcal postantibiotic effects (PAEs) were 0.7 to 1.8 and 0.7 to 2.4 h, respectively. For Escherichia coli and Pseudomonas aeruginosa, PAEs were 2.4 to 4.4 h. Pneumococcal and staphylococcal postantibiotic sub-MIC effects (PA-SMEs) (0.4 times the MIC) were 2.3 to 3.7 and 2.4 to > 9.2 h, respectively, and E. coli PA-SMEs (0.3 times the MIC) were 6.8 to > 12.0 h. For one P. aeruginosa strain, the PA-SME (0.4 times the MIC) was > 10 h; in the other, rapid bactericidal activity precluded measurement.
Similar articles
-
Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms.Antimicrob Agents Chemother. 1999 Oct;43(10):2574-5. doi: 10.1128/AAC.43.10.2574. Antimicrob Agents Chemother. 1999. PMID: 10508050 Free PMC article.
-
Pharmacodynamic studies of trovafloxacin and grepafloxacin in vitro against Gram-positive and Gram-negative bacteria.J Antimicrob Chemother. 2000 Jul;46(1):35-43. doi: 10.1093/jac/46.1.35. J Antimicrob Chemother. 2000. PMID: 10882686
-
Postantibiotic effects of garenoxacin (BMS-284756) against 12 gram-positive or -negative organisms.Antimicrob Agents Chemother. 2003 Mar;47(3):1140-2. doi: 10.1128/AAC.47.3.1140-1142.2003. Antimicrob Agents Chemother. 2003. PMID: 12604557 Free PMC article.
-
A review of the antimicrobial activity of the fluoroquinolones.J Chemother. 1990 Oct;2(5):280-94. doi: 10.1080/1120009x.1990.11739031. J Chemother. 1990. PMID: 2128638 Review.
-
Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.Eur J Clin Microbiol Infect Dis. 1998 Jun;17(6):405-12. doi: 10.1007/BF01691573. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9758283 Review.
Cited by
-
In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique.Antimicrob Agents Chemother. 2001 Jan;45(1):243-51. doi: 10.1128/AAC.45.1.243-251.2001. Antimicrob Agents Chemother. 2001. PMID: 11120973 Free PMC article.
-
Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.Antimicrob Agents Chemother. 2003 Oct;47(10):3352-6. doi: 10.1128/AAC.47.10.3352-3356.2003. Antimicrob Agents Chemother. 2003. PMID: 14506057 Free PMC article.
-
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.Antimicrob Agents Chemother. 1998 Nov;42(11):3028-31. doi: 10.1128/AAC.42.11.3028. Antimicrob Agents Chemother. 1998. PMID: 9797249 Free PMC article.
References
-
- Boswell F J, Andrews J M, Wise R. Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa. J Antimicrob Chemother. 1997;39:811–814. - PubMed
-
- Cars O, Odenholt-Tornqvist I. The postantibiotic subMIC effect in vitro and in vivo. J Antimicrob Chemother. 1993;31:159–166. - PubMed
-
- Craig, W. 1993. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens. Eur. J. Clin. Microbiol. Infect. Dis. 12(Suppl. 1):6–8. - PubMed
-
- Craig W A, Gudmundsson S. Postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine. Baltimore, Md: The Williams & Wilkins Co.; 1996. pp. 296–329.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources